Within two days, patients are cured of the disease and no longer transmit the parasite if they are bitten again by a mosquito.
This discovery was made by Radboud university medical center scientists and international colleagues during a research project conducted in Mali. The results will be published in The Lancet Infectious Diseases on February 6th.
The pressure is on when it comes to antimalarial medicines, as malaria parasites are increasingly resistant to the artemisinin-based combination therapies that are currently used. In addition, these medicines do very little to stop the spread of malaria, as the parasites remain in the blood for a long time, with the chance that other mosquitos are infected if they feed on the patient. The parasites split in the patient’s red blood cells, forming male and female sex cells (gametocytes). If another mosquito bites the patient, it sucks up the sex cells and these are fertilized in the mosquito’s stomach. The offspring then find their way to the mosquito’s salivary glands, where the cycle starts again.
Effect after just 48 hours
The gametocytes can stay in a person’s body for several weeks following treatment for malaria. In the new study in Mali, Radboudumc researchers added methylene blue to the artemisinin-based combination therapy. Methylene blue is a blue dye that is used in laboratories to distinguish dead cells from living cells. Adding the dye to the antimalaria medicine ensured that patients no longer infected other mosquitos, within as little as 48 hours. Patients who were not given methylene blue were able to infect other mosquitos for at least a week. Researcher Teun Bousema (Radboudumc) coordinated the study which was conducted together with the University of California (UCSF) and the Malaria Research and Training Center (MRTC). Bousema: “We noted that the male parasites disappeared from the bloodstream more quickly than the female parasites.”
Blue urine
Encouraged by the promising results of laboratory experiments, Bousema’s team has investigated for the first time the effect of methylene blue on the spread of malaria amongst humans. Bousema: “Methylene blue is very promising, because it can prevent the spread of malaria within such a short time following treatment. There are also indications that methylene blue also works well in species that are resistant to certain medicines.” The dye is safe and was tolerated well by patients. There is however just one awkward side effect: “I have used it myself, and it turns your urine bright blue. This is something that we need to solve, because it could stop people from using it.”
Malaria causes 430?000 deaths every year. Infection is caused by the bite of a malaria-carrying mosquito, and 90% of all deaths are in Africa, mostly amongst children. Malaria prevention focuses primarily on the use of mosquito nets, insecticides and medicine and, as a result, the number of deaths due to malaria has almost halved in the last ten years.
Learn more: Dye kills malaria parasites at speed not seen before
The Latest on: Malaria parasites
[google_news title=”” keyword=”malaria parasites” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria parasites
- Malaria Newson April 26, 2024 at 5:00 pm
Apr. 3, 2024 — A recent breakthrough sheds light on how the malaria parasite, Plasmodium falciparum, invades human red blood cells. The study reveals the role of a sugar called sialic acid in ...
- Experimental NIH malaria monoclonal antibody protective in Malian childrenon April 26, 2024 at 12:23 pm
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results ...
- Malaria parasites can evade rapid tests, threatening eradication goalson April 25, 2024 at 11:58 am
Genetic mutations are making Plasmodium falciparum, parasites that cause malaria, invisible to rapid tests. New, more sensitive tests could help.
- Q&A: Scientist who helped design R21 anti-malaria vaccine reflects on 30 years of research, and what it promiseson April 25, 2024 at 9:17 am
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the RTS,S and the R21 vaccines.
- What are biotech companies doing to tackle malaria?on April 25, 2024 at 7:40 am
As we observe World Malaria Day on April 25, let’s take a look at some of the latest progress and new treatments against malaria.
- Vaccines are a glimmer of hope against malaria, but the battle has only just begunon April 25, 2024 at 6:10 am
By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark shadow over nearly half of the world’s population, claiming victims ...
- Why the fight against malaria is having a ‘Red Queen’ momenton April 25, 2024 at 4:41 am
For malaria researchers and practitioners, this sensation feels all too familiar. Despite several exciting advances, efforts to tackle the parasitic pathogen have stalled since 2015: then, according ...
- R21 Anti-Malaria Vaccine Is a Game Changer - Scientist Who Helped Design It Reflects On 30 Years of Research, and What It Promises [analysis]on April 24, 2024 at 11:10 pm
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the RTS,S and the R21 vaccines. Adrian Hill, director of the Jenner Institute at ...
- Can climate change accelerate transmission of malaria? New research sheds light on impacts of temperatureon April 24, 2024 at 10:41 am
Malaria is a mosquito-borne disease caused by a parasite that spreads from bites of infected female Anopheles mosquitoes. If left untreated in humans, malaria can cause severe symptoms, health ...
via Bing News